Rhenman & Partners Asset Management’s CVS Health CVS Stock Holding History

Rhenman & Partners Asset Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.2M	Buy	336,500 +1,000	+0.3%	+$77K	2.98%	5
2025 Q4	$26.6M	Buy	335,500 +58,138	+21%	+$4.58M	2.49%	7
2025 Q3	$20.9M	Sell	277,362 -18,000	-6%	-$1.23M	2.31%	9
2025 Q2	$20.4M	Buy	295,362 +59,500	+25%	+$3.9M	2.58%	8
2025 Q1	$16M	Sell	235,862 -31,638	-12%	-$1.89M	1.84%	23
2024 Q4	$12M	Buy	267,500 +83,500	+45%	+$4.68M	1.23%	32
2024 Q3	$11.6M	Buy	+184,000	New	+$10.7M	0.94%	36
2024 Q1	–	Sell	-137,500	Closed	-$10.9M	–	85
2023 Q4	$10.9M	Sell	137,500 -162,500	-54%	-$11.6M	1.08%	35
2023 Q3	$20.9M	Buy	300,000 +52,000	+21%	+$3.68M	2.26%	16
2023 Q2	$17.1M	Buy	248,000 +75,000	+43%	+$5.34M	1.81%	25
2023 Q1	$12.9M	Buy	173,000 +2,000	+1%	+$168K	1.42%	27
2022 Q4	$15.9M	Sell	171,000 -54,000	-24%	-$5.21M	1.66%	24
2022 Q3	$21.3M	Sell	225,000 -65,000	-22%	-$6.43M	2.23%	14
2022 Q2	$26.9M	Buy	290,000 +55,000	+23%	+$5.37M	3.05%	8
2022 Q1	$23.8M	Sell	235,000 -175,000	-43%	-$18.4M	2.35%	9
2021 Q4	$42.5M	Buy	410,000 +10,000	+3%	+$924K	2.83%	9
2021 Q3	$33.9M	Buy	400,000 +20,000	+5%	+$1.68M	2.38%	11
2021 Q2	$31.7M	Sell	380,000 -70,000	-16%	-$5.73M	2.15%	9
2021 Q1	$33.9M	Buy	450,000 +30,000	+7%	+$2.19M	2.36%	11
2020 Q4	$28.7M	Buy	420,000 +180,000	+75%	+$11.7M	2.34%	9
2020 Q3	$14M	Buy	240,000 +13,000	+6%	+$809K	1.25%	34
2020 Q2	$14.7M	Sell	227,000 -33,000	-13%	-$2.08M	1.59%	27
2020 Q1	$15.4M	Buy	260,000 +119,786	+85%	+$8M	2.16%	12
2019 Q4	$10.4M	Sell	140,214 -163,554	-54%	-$11.5M	1.14%	37
2019 Q3	$19.2M	Sell	303,768 -40,000	-12%	-$2.37M	2.4%	12
2019 Q2	$18.7M	Sell	343,768 -10,100	-3%	-$544K	2.06%	16
2019 Q1	$19.1M	Sell	353,868 -55,000	-13%	-$3.39M	2.23%	15
2018 Q4	$26.8M	Sell	408,868 -30,000	-7%	-$2.24M	3.06%	4
2018 Q3	$34.5M	Buy	438,868 +65,000	+17%	+$4.65M	3.46%	2
2018 Q2	$24.1M	Buy	373,868 +120,000	+47%	+$7.91M	2.46%	7
2018 Q1	$15.8M	Buy	+253,868	New	+$18.2M	1.95%	22
2017 Q4	–	Sell	-120,000	Closed	-$9.76M	–	96
2017 Q3	$9.76M	Buy	120,000 +35,000	+41%	+$2.77M	1.25%	32
2017 Q2	$6.84M	Sell	85,000 -45,000	-35%	-$3.55M	0.98%	38
2017 Q1	$10.2M	Sell	130,000 -10,000	-7%	-$798K	1.62%	25
2016 Q4	$11M	Sell	140,000 -20,000	-13%	-$1.62M	2.12%	14
2016 Q3	$14.2M	Buy	160,000 +40,000	+33%	+$3.78M	2.26%	12
2016 Q2	$11.5M	Buy	120,000 +15,000	+14%	+$1.49M	2.04%	13
2016 Q1	$10.9M	Sell	105,000 -75,000	-42%	-$7.29M	2.16%	11
2015 Q4	$17.6M	Buy	180,000 +83,000	+86%	+$8.13M	2.66%	5
2015 Q3	$9.36M	Sell	97,000 -87,000	-47%	-$9.15M	1.49%	27
2015 Q2	$19.3M	Buy	184,000 +39,000	+27%	+$3.98M	2.32%	7
2015 Q1	$15M	Buy	145,000 +48,000	+49%	+$4.86M	2.52%	10
2014 Q4	$9.34M	Buy	97,000 +25,000	+35%	+$2.2M	2.71%	3
2014 Q3	$5.73M	Buy	72,000 +22,000	+44%	+$1.73M	1.68%	16
2014 Q2	$3.77M	Sell	50,000 -38,442	-43%	-$2.91M	1.12%	28
2014 Q1	$6.62M	Sell	88,442 -18,558	-17%	-$1.31M	1.99%	11
2013 Q4	$7.66M	Buy	+107,000	New	+$6.87M	3%	4

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rhenman & Partners Asset Management's CVS Position: Q1 2026 in Review

Rhenman & Partners Asset Management increased its CVS Health (CVS) stake by 0.3% in Q1 2026, buying an estimated $77K and bringing the position to 336,500 shares worth $24.2M. The position accounts for 2.98% of the portfolio, ranked #5.

Rhenman & Partners Asset Management first reported a position in CVS in Q4 2013 and has held it in 47 quarters since. The position peaked at $42.5M in Q4 2021. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Rhenman & Partners Asset Management held 336,500 shares of CVS Health worth $24.2M as of Q1 2026.
Rhenman & Partners Asset Management bought 1,000 CVS Health shares in Q1 2026, an estimated $77K.
CVS Health made up 2.98% of Rhenman & Partners Asset Management's portfolio in Q1 2026, its #5 holding.
Rhenman & Partners Asset Management first reported a position in CVS Health in Q4 2013 and has held it in 47 quarters since.
Rhenman & Partners Asset Management's CVS Health position peaked at $42.5M in Q4 2021.
1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2026, filed 14 May 2026.